Provider Resources

Buprenorphine is an effective treatment for opioid use disorder. It prevents drug withdrawal, blocks, or diminishes the effects of other opioids, and prevents the powerful cravings that accompany the reduction of opioid use.

The risk of an opioid overdose is also reduced for persons taking buprenorphine. Recently passed legislation (Chapter 432 of the Laws of 2021) will significantly expand buprenorphine and methadone access in correctional settings.

Below are Drug User Health Resources and Trainings, Buprenorphine, Harm Reduction and Emerging Drug User Health Resources for Providers.

Resources for Pharmacists

  • ASAM American Society of Addiction Medicine
  • APhA American Pharmacists Association
  • PSSNY Pharmacist Society of the State of NY
  • Pharmacy Buprenorphine Assistance Program (Bupe-AP) - The Buprenorphine Assistance Program is available at all AIDS Drug Assistance Program (ADAP) participating pharmacies and covers the cost of buprenorphine products indicated to treat substance use disorder (SUD) for persons who are uninsured or underinsured and not able to cover the cost of these products. This program covers copays and coordinates with patients’ insurers to cover any other out-of-pocket costs. To be eligible for Buprenorphine Assistance Program, people need to be enrolled in the program.
    • To find out if a patient qualifies for the program and where they can be enrolled, call 518-459-1641
    • Pharmacies must submit claims electronlically, using NCPDP version D.0 including the COB segment of the transaction, if appropriate. The Point-of-Sale system will verify the participant's eligibility and specific drug coverage as well as process and adjudicate claims. Claims must be submitted using the following payer information. For questions regarding participating pharmacies, NDC or claim processing, please call 800-542-2437 or 1-844-682-4058.
    • Bupe-AP Pharmacy Palm Card (12047)

Training and Resources for Corrections